ASSMA BEN AISSA, MD-PhD

201 posts

ASSMA BEN AISSA, MD-PhD

ASSMA BEN AISSA, MD-PhD

@Assma2018

Medical Oncologist, PhD immuno-oncology

University Hospital of Geneva, Katılım Mayıs 2018
180 Takip Edilen41 Takipçiler
ASSMA BEN AISSA, MD-PhD
ASSMA BEN AISSA, MD-PhD@Assma2018·
@FranceskAlbs I am impressed and touched by your unstoppable courage, commitment, resilience and determination!! You are definitely not alone, the whole universe is with you because your are fighting for justice and dignity, not for you but for the most oppressed. Evil people can't see it.
English
0
0
0
96
Dr Amol Akhade
Dr Amol Akhade@SuyogCancer·
This is growing. We have above 700 members now from all over the world . With different sub groups , we have tumor specific discussions. Those ( practicing oncologists and fellows) who want to join, do DM me 🙂. Join Wisdom without borders 🙂.
Dr Amol Akhade tweet mediaDr Amol Akhade tweet media
English
19
9
55
9.6K
ASSMA BEN AISSA, MD-PhD retweetledi
soria
soria@jsoriamd·
Cancer-associated Cachexia is a lethal metabolic syndrome marked by systemic inflammation, CNS appetite dysregulation, & muscle/fat loss—better characterized with imaging. Prevalent in cancers like pancreatic/lung, it's linked to IL-6, GDF-15, & tumor-driven energy drain. Trials targeting CNS and inflammation (e.g., Ghrelin receptor agonist, anti-GDF15 Ab) show promise. #AACR25 #Cancer #cachexia aacrjournals.org/cancerdiscover…
soria tweet media
English
3
57
207
19.4K
ASSMA BEN AISSA, MD-PhD retweetledi
nature
nature@Nature·
Nature research paper: Clonal driver neoantigen loss under EGFR TKI and immune selection pressures go.nature.com/4hJsDxd
Deutsch
1
7
26
13.8K
ASSMA BEN AISSA, MD-PhD retweetledi
Janduslab
Janduslab@janduslab·
📢 Currently recruiting healthy male participants for our cutting-edge study on #CognitiveImmunity Interested? Scan the QR code to join us!
Janduslab tweet media
English
0
2
4
392
ASSMA BEN AISSA, MD-PhD retweetledi
Cancer Cell
Cancer Cell@Cancer_Cell·
Online Now: Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors dlvr.it/T8b8JK
Cancer Cell tweet media
English
0
117
297
42.2K
Janduslab
Janduslab@janduslab·
Congratulations to @maracene on her successful PhD defense!🥳 We wish you all the best for your future!😊
Janduslab tweet media
Geneva, Switzerland 🇨🇭 English
1
1
8
818
Rob Hynds
Rob Hynds@robhynds·
Excited to share the lab's first paper. A great way to mark #RareDiseaseDay yesterday. Thanks to everyone who has helped.
Epithelial Cell Biology in ENT Research Group@EpiCENTR_ICH

Our new paper @MolTherapy provides proof-of-concept for a combined cell and gene therapy for airway epidermolysis bullosa (EB). With colleagues @GreatOrmondSt, we investigated airway disease in EB, a group of rare genetic disorders involving defective cell adhesion 🧵... (1/8)

English
4
0
33
5.9K
ASSMA BEN AISSA, MD-PhD retweetledi
Ehsan Ghorani
Ehsan Ghorani@EGhorani·
Rafi Ahmed's 75th birthday symposium, addressing a room full of former trainees and their trainees "The best gift is seeing your wonderful science...It's incredible how lucky I've been. This is my message to you: whatever you do, being a good human being is the most important"
Ehsan Ghorani tweet media
English
2
12
115
19.6K
ASSMA BEN AISSA, MD-PhD retweetledi
Quezada Lab
Quezada Lab@QuezadaLab·
Our PI, Sergio Quezada has written a Nature Cancer commentary on neoantigen prediction along with our amazing EU funded collaborators: Achilles Therapeutics plc, Weizmann Institute of Science, DTU Health Tech and UCL Cancer Institute. Check it out here: rdcu.be/dtIHQ
English
1
4
25
3K
ASSMA BEN AISSA, MD-PhD retweetledi
Simone Zaccaria
Simone Zaccaria@ZaccaSimo·
Happy for CONIPHER available to all! ⚠️Remember ALL related TRACERx 421 processed data are publicly avail: 👉doi.org/10.5281/zenodo… Explore them following the oustanding wiki in Python or R by @LucreziaPatruno and Maria in my and @NickyMcGranahan group 👉github.com/McGranahanLab/…
Nicholas McGranahan@NickyMcGranahan

CONIPHER, our method for automated reconstruction of tumour subclonal structure and phylogeny that we used in our recently published TRACERx studies, is now out in Nature Protocols! (nature.com/articles/s4159…). Welcome to the CONIPHER TREEtorial, just in time for Christmas! 🌲 1/n

English
1
8
31
5.5K
ASSMA BEN AISSA, MD-PhD retweetledi
Denis Migliorini
Denis Migliorini@MiglioriniDenis·
Out today in @NatureCancer we had a great time collaborating with Michele De Palma and Mathias Heikenwaelder’s groups. We contributed in combining engineered dendritic cell progenitors with CAR-T cells in an aggressive glioma mouse model showing promising synergistic effects.
EPFL@EPFL_en

Cancer biologists at EPFL, @unige_en and @DKFZ have developed a novel immunotherapy that does not require knowledge of a tumor’s antigenic makeup. The new results may pave the way to first-in-kind clinical applications. @epflsv go.epfl.ch/feabda

Geneva, Switzerland 🇨🇭 English
2
5
35
5.2K
Janduslab
Janduslab@janduslab·
Thanks to the scientific committee of the #SCCL for awarding the prize for the best talk to our PhD student @maracene. Amazing meeting and inspiring discussions🤩
Janduslab tweet media
Geneva, Switzerland 🇨🇭 English
2
0
10
759
ASSMA BEN AISSA, MD-PhD retweetledi
ASH
ASH@ASH_hematology·
The risk of blood clots largely disappears within 2 to 4 weeks after stopping hormone-based birth control, according to a new study in @BloodJournal. Read more: loom.ly/uqC2RnA @MarcBlondon
ASH tweet media
English
1
9
23
5.4K
ASSMA BEN AISSA, MD-PhD retweetledi
Janduslab
Janduslab@janduslab·
On Sunday @bennifiordi will be present at the @ESHaematology Conference in Estoril (Portugal) with a poster on her interesting project on ACUTE MYELOID LEUKEMIA! Go to find out more about her results🤩
Janduslab tweet media
English
0
2
5
389

Keşfet

@FranceskAlbs @SuyogCancer @QuezadaLab @CR_UK @uclcancer @janduslab @maracene @robhynds